Health, beauty, and wellness is a rapidly growing industry worldwide. Stay up to date with global news, trends, topics, and more with the AIHBA news feed.
The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 participants found to have serious prostate cancer, 15 had a ‘low’ PSA score that would have meant they were not referred […]
MRI scans improve prostate cancer diagnosis in screening trial Read More »
Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression in mice models. Estrogen, a group of female hormones, is known to be involved in cancer progression, especially breast cancer. About 75 % of breast cancers are estrogen-sensitive: they express
Estrogen-negative cancers respond to anti-estrogenic therapies Read More »
Despite the many changes in school culture since the 1960s, a new study reveals that some things never change: life is harder for middle school students who are not attractive and for those who are not athletic. As children head back to school, the first-of-its-kind longitudinal study by Florida Atlantic University helps to explain why
Perils of not being attractive or athletic in middle school Read More »
A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of the disease. Researchers at Duke Cancer Institute enrolled 50 Black and 50 white men with
Study confirms racial differences in response to prostate cancer treatment Read More »
Patients with localised prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of the condition remain high. Until now, the precise mechanism behind the spread of the tumour has not been fully explained. But an international research team headed by MedUni Vienna has succeeded in decoding the
Research into use of diabetes medication for treatment of metastatic prostate cancer Read More »
A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate cancer. Using tissue samples and cell models from patients, Joshi Alumkal, M.D., Wicha Family Professor of Oncology and leader of
New approach to target a deadly form of prostate cancer Read More »
Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells — and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers. The findings shed light on how androgens interact with their receptors inside cells to affect gene activity. This
New insights into androgen's action could boost battle against prostate cancer Read More »
Dr Bock, under the mentorship of Distinguished Professor Dietmar Hutmacher, from QUT Centre for Biomedical Technologies, has focused her research on bone metastases from breast and prostate cancers. She developed 3D miniature bone-like tissue models in which 3D printed biomimetic scaffolds are seeded with patient-derived bone cells and tumour cells to be used as clinical
Anti-androgen therapy can fuel spread of bone tumors in advanced prostate cancer Read More »
Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research group has published a study in The Lancet Oncology, which shows that the addition of a novel blood test, the Stockholm3 test, can reduce the number of MRIs performed
New blood test improves prostate cancer screening Read More »
Researchers at Monash University have established one of the world’s largest collections of living tumours from prostate cancer patients, accelerating the testing of new treatments for prostate cancer and leading to faster patient benefit. One of the most common cancers, prostate cancer is also one of the most difficult to study in the laboratory, with
Patients helping researchers to advance treatments for prostate cancer Read More »
Thank you for visiting the AIHBA website, which language would you like to view the site in?
欢迎访问AIHBA网站!
请在下方选择您希望使用的语言，以便更好地浏览我们的网站
中文
English language